Skip to main content

Table 2 No difference in anti-HSA-MAA+ RA patients between the main ELISA and two modified protocols

From: Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

Isotype

Anti-MAA+ RA patients %a

Difference protocolsb

Main

1st

2nd

p main vs. 1st

p main vs. 2nd

IgG

14.6

14.9

8.3

0.7

0.4

IgM

6.3

8.3

-

1

-

IgA

6.3

4.2

-

1

-

  1. The main protocol was used in Fig. 1 and Table 1. The 1st modified protocol changed the HSA source, increased the ratio of malondialdehyde to acetaldehyde to 4:1, replaced BSA for casein in the blocking buffer and the adduct purification system. The 2nd modified protocol was as the 1st except for the 2:1 MDA to AA ratio and the anti-Fcγ secondary antibody instead of the anti-(H + L) IgG antibody
  2. aPatients and controls, 48 and 48, were randomly selected from the Santiago collection. The cut-off for positivity was specific for each protocol at the estimated 98th percentile
  3. bComparison of the protocols with the McNemar test (with the Yates correction) for paired samples